Pregnancy outcome in survivors of advanced Hodgkin disease

Cancer. 1992 Aug 1;70(3):688-92. doi: 10.1002/1097-0142(19920801)70:3<688::aid-cncr2820700325>3.0.co;2-v.

Abstract

Background: Pregnancy outcome was reported by 139 survivors of advanced Hodgkin disease treated on nine protocols of Cancer and Leukemia Group B from 1966 to 1986.

Methods: These patients provided data on 302 singleton pregnancies of a duration of at least 20 weeks that occurred before, during, or after treatment for Hodgkin disease (252, 26, and 24 pregnancies, respectively).

Results: There were 4 perinatal deaths, as compared with 5.7 expected. Cancer subsequently developed in 2 offspring (expected, 1.2). However, 22 newborn infants had low a birth weight, exceeding the expected number of 13.7 (relative risk 1.6; 95% confidence interval, 1.0-2.4). The excess number of low weight births occurred primarily during the period of Hodgkin disease diagnosis and treatment but is based on small numbers.

Conclusion: No increase in adverse outcome occurred in pregnancies that antedated the development of Hodgkin disease.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Epidemiologic Methods
  • Female
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / physiopathology*
  • Humans
  • Male
  • Middle Aged
  • Pregnancy
  • Pregnancy Complications / epidemiology*
  • Pregnancy Outcome / epidemiology*